Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Cancer Letters
|
December 18, 2017
Genetic variant repressing ADH1A expression confers susceptibility to esophageal squamous-cell carcinoma
Qionghua Cui, Linna Peng, Lixuan Wei, et al.
Theranostics
|
March 25, 2020
Metabolic remodeling by TIGAR overexpression is a therapeutic target in esophageal squamous-cell carcinoma
Jiahui Chu, Xiangjie Niu, Jiang Chang, et al.
The Oncologist
|
July 1, 2025
Timing and clinical significance of chemotherapy in patients with resected gastric adenocarcinoma: a population-based cohort study
Di Zhang, Qian Yang, Chunwang Ji, et al.
Genomics, Proteomics & Bioinformatics
|
September 13, 2018
CCGD-ESCC: A Comprehensive Database for Genetic Variants Associated with Esophageal Squamous Cell Carcinoma in Chinese Population
Linna Peng, Sijin Cheng, Yuan Lin, et al.
Cancer Communications (London, England)
|
March 20, 2024
Conserved immuno-collagenic subtypes predict response to immune checkpoint blockade
Jie Mei, Yun Cai, Rui Xu, et al.
Signal Transduction and Targeted Therapy
|
August 31, 2021
VAV2 is required for DNA repair and implicated in cancer radiotherapy resistance
Weiling Liu, Chuanwang Miao, Shaosen Zhang, et al.
Cancer Communications (London, England)
|
May 15, 2025
N<sup>6</sup>-methyladenosine-regulated exosome biogenesis orchestrates an immunosuppressive pre-metastatic niche in gastric cancer peritoneal metastasis
Song Li, Jianyuan Zhou, Shuang Wang, et al.
Journal of Advanced Research
|
May 28, 2025
Genomic landscape of paired primary and peritoneal metastatic lesions in gastric cancer highlights evolutionary dynamics and mutational drivers
Song Li, Weiwei Zhang, Qian Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 26, 2026
First-Line Disitamab Vedotin, Tislelizumab, and S-1 in HER2-Overexpressing Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: A Single-Arm, Phase II Trial
Song Li, Zimin Liu, Yanguo Liu, et al.
Nature Communications
|
May 27, 2017
Genomic analysis of oesophageal squamous-cell carcinoma identifies alcohol drinking-related mutation signature and genomic alterations
Jiang Chang, Wenle Tan, Zhiqiang Ling, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Cancer Letters
|
December 18, 2017
Genetic variant repressing ADH1A expression confers susceptibility to esophageal squamous-cell carcinoma
Qionghua Cui, Linna Peng, Lixuan Wei, et al.
Theranostics
|
March 25, 2020
Metabolic remodeling by TIGAR overexpression is a therapeutic target in esophageal squamous-cell carcinoma
Jiahui Chu, Xiangjie Niu, Jiang Chang, et al.
The Oncologist
|
July 1, 2025
Timing and clinical significance of chemotherapy in patients with resected gastric adenocarcinoma: a population-based cohort study
Di Zhang, Qian Yang, Chunwang Ji, et al.
Genomics, Proteomics & Bioinformatics
|
September 13, 2018
CCGD-ESCC: A Comprehensive Database for Genetic Variants Associated with Esophageal Squamous Cell Carcinoma in Chinese Population
Linna Peng, Sijin Cheng, Yuan Lin, et al.
Cancer Communications (London, England)
|
March 20, 2024
Conserved immuno-collagenic subtypes predict response to immune checkpoint blockade
Jie Mei, Yun Cai, Rui Xu, et al.
Signal Transduction and Targeted Therapy
|
August 31, 2021
VAV2 is required for DNA repair and implicated in cancer radiotherapy resistance
Weiling Liu, Chuanwang Miao, Shaosen Zhang, et al.
Cancer Communications (London, England)
|
May 15, 2025
N<sup>6</sup>-methyladenosine-regulated exosome biogenesis orchestrates an immunosuppressive pre-metastatic niche in gastric cancer peritoneal metastasis
Song Li, Jianyuan Zhou, Shuang Wang, et al.
Journal of Advanced Research
|
May 28, 2025
Genomic landscape of paired primary and peritoneal metastatic lesions in gastric cancer highlights evolutionary dynamics and mutational drivers
Song Li, Weiwei Zhang, Qian Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 26, 2026
First-Line Disitamab Vedotin, Tislelizumab, and S-1 in HER2-Overexpressing Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: A Single-Arm, Phase II Trial
Song Li, Zimin Liu, Yanguo Liu, et al.
Nature Communications
|
May 27, 2017
Genomic analysis of oesophageal squamous-cell carcinoma identifies alcohol drinking-related mutation signature and genomic alterations
Jiang Chang, Wenle Tan, Zhiqiang Ling, et al.
Page
of 7